Email communications may be an effective strategy for improving clinician engagement with prescription drug monitoring ...

A personalized 3-month resistance exercise program improved walking distance and HRQOL in adults with persistent COVID-19 symptoms.

With medication for opioid use disorder, the benefit of retention on patient survival persists through about 4 to 5 years of treatment.

Women endurance athletes experience a high frequency of menopausal symptoms, some of which are perceived to negatively impact performance.

An AHA scientific statement explores how AI, mobile imaging, and telehealth support acute stroke triage and treatment decisions within virtual networks.

Service-bridging mechanism reduces referral wait times and improves symptoms in older adults with mild to moderate depression.

Adverse prenatal exposures are associated with altered developmental trajectories, impacting psychopathology and maturation into adolescence.

Researchers identified unique trajectories of autistic social traits in youth born extremely preterm from age 10 to 17.

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Increased risk for suicide may be associated with head injuries, highlighting the connection between head trauma and ...

FDA grants Priority Review to AXS-05 (dextromethorphan/bupropion) for the treatment of agitation associated with Alzheimer disease.

Long-term research indicates that anorexia nervosa onset in adolescence predicts higher psychiatric outpatient care and medication use.